Correlation Between Eterna Therapeutics and Structure Therapeutics
Can any of the company-specific risk be diversified away by investing in both Eterna Therapeutics and Structure Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eterna Therapeutics and Structure Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eterna Therapeutics and Structure Therapeutics American, you can compare the effects of market volatilities on Eterna Therapeutics and Structure Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eterna Therapeutics with a short position of Structure Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eterna Therapeutics and Structure Therapeutics.
Diversification Opportunities for Eterna Therapeutics and Structure Therapeutics
0.82 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Eterna and Structure is 0.82. Overlapping area represents the amount of risk that can be diversified away by holding Eterna Therapeutics and Structure Therapeutics America in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Structure Therapeutics and Eterna Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eterna Therapeutics are associated (or correlated) with Structure Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Structure Therapeutics has no effect on the direction of Eterna Therapeutics i.e., Eterna Therapeutics and Structure Therapeutics go up and down completely randomly.
Pair Corralation between Eterna Therapeutics and Structure Therapeutics
Given the investment horizon of 90 days Eterna Therapeutics is expected to under-perform the Structure Therapeutics. In addition to that, Eterna Therapeutics is 2.0 times more volatile than Structure Therapeutics American. It trades about -0.28 of its total potential returns per unit of risk. Structure Therapeutics American is currently generating about -0.1 per unit of volatility. If you would invest 4,192 in Structure Therapeutics American on September 20, 2024 and sell it today you would lose (1,044) from holding Structure Therapeutics American or give up 24.9% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Strong |
Accuracy | 100.0% |
Values | Daily Returns |
Eterna Therapeutics vs. Structure Therapeutics America
Performance |
Timeline |
Eterna Therapeutics |
Structure Therapeutics |
Eterna Therapeutics and Structure Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Eterna Therapeutics and Structure Therapeutics
The main advantage of trading using opposite Eterna Therapeutics and Structure Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eterna Therapeutics position performs unexpectedly, Structure Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Structure Therapeutics will offset losses from the drop in Structure Therapeutics' long position.Eterna Therapeutics vs. Arcus Biosciences | Eterna Therapeutics vs. Cullinan Oncology LLC | Eterna Therapeutics vs. Annexon | Eterna Therapeutics vs. Structure Therapeutics American |
Structure Therapeutics vs. Day One Biopharmaceuticals | Structure Therapeutics vs. X4 Pharmaceuticals | Structure Therapeutics vs. Inozyme Pharma | Structure Therapeutics vs. Acumen Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Complementary Tools
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Transaction History View history of all your transactions and understand their impact on performance | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |